Highlands Oncology Group
Highlands Oncology Group is a 30-physician, six-location community oncology practice in northwest Arkansas delivering comprehensive cancer care with an emphasis on oral oncolytic medications, in-house pharmacy dispensing, and remote patient monitoring for cancer patients.
- Company typePrivate
- Founded1996
- HeadquartersFayetteville, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
Highlands Oncology Group firmographics
Firmographics- Name
- Highlands Oncology Group
- Legal name
- Highlands Oncology Group
- Website
- https://highlandsoncologygroup.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Highlands Oncology Group is a 30-physician, six-location community oncology practice in northwest Arkansas delivering comprehensive cancer care with an emphasis on oral oncolytic medications, in-house pharmacy dispensing, and remote patient monitoring for cancer patients.
- Ownership category
- akta.pro rank
Highlands Oncology Group industry classification
Industry- Product category
- Oncology Services
- NAICS
- Other Outpatient Care Centers (62149), Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Highlands Oncology Group is headquartered
LocationHeadquarters
- HQ city
- Fayetteville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Highlands Oncology Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Patient Care Services: Healthcare services revenue generated from treating cancer patients including oral oncolytic medications, prescriptions, and monitoring services. Revenue is derived from insurance reimbursements, patient payments, and potentially in-house pharmacy dispensing.
Go-to-market motion1 record
Distribution channels1 record
Highlands Oncology Group product offering
Product offeringCore offering
Highlands Oncology Group is a community oncology practice that delivers in-clinic cancer treatments (including chemotherapy and oral oncolytics), supportive care such as massage therapy, in-house pharmacy dispensing, and remote patient monitoring to cancer patients across northwest Arkansas. It operates six clinic locations with approximately 30 physicians, complemented by financial assistance and grant programs that supported 800 patients in the most recent reporting period.
Differentiator
Problem solved
Functional benefit
Products and services
- Chemotherapy (Infusion) Treatment
Quantifiable outcome
- Served approximately 1,900 oral oncolytics patients between August 2024 and August 2025
- +2 more outcomes
Companies that use Highlands Oncology Group
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Highlands Oncology Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Highlands Oncology Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Regional Hospitals (unspecified)corePartnership with regional hospitals in northwest Arkansas to coordinate patient care for cancer patients requiring oral oncolytic treatments. Enables referral pathways and integrated care delivery between hospital systems and the oncology practice.
- Nonprofit Organizations (unspecified)coreCollaboration with nonprofit organizations to support patient access to oral oncolytic medications. Partnership facilitates grant and funding assistance programs, helping 800 patients obtain financial support for their cancer treatments between August 2024 and August 2025.
Scale indicators5 records
Highlands Oncology Group competitors and assessment
Company assessmentBroad incumbents
- The US Oncology Network (McKesson): Largest aggregator of community oncology practices in the U.S.; comparable because it offers the same community-based oncology services and represents a primary competitive/affiliation counterpart for Highlands.
- City of Hope (formerly Cancer Treatment Centers of America): National specialty oncology system offering comprehensive cancer treatment; comparable as a broader incumbent delivering outpatient chemotherapy, oral oncolytics, and remote care capabilities that compete with community oncology for complex cases.
- Sarah Cannon Research Institute: Hospital-affiliated oncology network providing community-based cancer care and clinical trials; comparable as an incumbent in the same outpatient oncology delivery and oral therapy management space.
Direct peers
- OneOncology: National network platform partnering with independent community oncology practices; directly comparable as a model for how Highlands could scale, access group purchasing, and deploy standardized care pathways including oral oncolytic management.
- Florida Cancer Specialists & Research Institute: Large multi-site community oncology practice providing chemotherapy, oral oncolytics, and clinical research across Florida; directly comparable business model of physician-owned, multi-clinic community oncology with in-house dispensing and care coordination.
- Tennessee Oncology: Multi-site independent community oncology practice with in-house pharmacy, oral oncolytic management, and integrated supportive care; closely comparable operating model to Highlands.
Others
- Equicare Health (Varian/Siemens Healthineers): Vendor of oncology care coordination and remote patient monitoring software used by cancer centers; adjacent comparable for the technology layer that supports Highlands' RPM and oral oncolytic workflow.
Regional players
- Nebraska Cancer Specialists: Mid-sized multi-physician community oncology practice in the Midwest offering chemotherapy, oral oncolytics, and supportive services; structurally similar to Highlands but operating in a different geographic market.
- Willamette Valley Cancer Institute and Research Center: Multi-physician community oncology practice in Oregon with oral oncolytic management and clinical trials; relevant comparable for Highlands' community oncology + oral therapy + monitoring model in a different region.
Emerging players
- OncoHealth: Specialty oncology platform providing remote symptom monitoring, care navigation, and oral therapy adherence support; directly comparable to Highlands' award-winning remote patient monitoring model for oral oncolytic patients.
Market position
Customer concentration
Highlands Oncology Group social profiles
Digital presenceHighlands Oncology Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Highlands Oncology Group leadership team
Management profileNumber of profiles
Profiles1 record
Highlands Oncology Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Highlands Oncology Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Highlands Oncology Group
What does Highlands Oncology Group do?
Highlands Oncology Group is a community oncology practice that delivers in-clinic cancer treatments (including chemotherapy and oral oncolytics), supportive care such as massage therapy, in-house pharmacy dispensing, and remote patient monitoring to cancer patients across northwest Arkansas. It operates six clinic locations with approximately 30 physicians, complemented by financial assistance and grant programs that supported 800 patients in the most recent reporting period.
Is Highlands Oncology Group a public or private company?
Highlands Oncology Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Highlands Oncology Group founded?
Highlands Oncology Group was founded in 1996. It employs 501 to 1,000 people.
Where is Highlands Oncology Group based?
Highlands Oncology Group is headquartered in Fayetteville, United States, in the North America region.
How does Highlands Oncology Group make money?
One revenue line is on record: patient Care Services.
Who are Highlands Oncology Group's main competitors?
Broad incumbents on record are The US Oncology Network (McKesson), City of Hope (formerly Cancer Treatment Centers of America) and Sarah Cannon Research Institute. Direct peers are OneOncology, Florida Cancer Specialists & Research Institute and Tennessee Oncology. Equicare Health (Varian/Siemens Healthineers) is listed as an others. Regional players are Nebraska Cancer Specialists and Willamette Valley Cancer Institute and Research Center. OncoHealth is listed as an emerging player.
Does Highlands Oncology Group have an API?
No public API is recorded for Highlands Oncology Group.
What industry is Highlands Oncology Group in?
Highlands Oncology Group's product category is Oncology Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 62149 and its SIC code is 8011.